Chemotherapy Myths — What the Evidence Actually Says

Chemotherapy drugs are metabolised and cleared by your body after each cycle, as happens with most medications. The drugs do target rapidly dividing cells throughout the body — including normal cells in hair follicles, the gut lining, and bone marrow — which is why side effects occur in those areas specifically. That mechanism is not the same as permanent poisoning. After treatment ends, the affected normal tissues recover in most cases.

Dying from a cancer that treatment could not control is not the same as dying from the treatment itself. This distinction is genuinely difficult to see from outside the full medical picture. When someone dies during or after chemotherapy, connecting the two is a natural response to loss. In most cases, it is the cancer — often progressing for months or years before diagnosis — that is the cause of death. Believing otherwise harms the next family member who has to decide whether to accept treatment.

All treatments that affect the body have the potential to cause harm. The word natural does not mean safe — arsenic is natural, as are many toxic plants. The relevant question is whether the evidence shows a treatment helps with cancer and what risks it carries. No Ayurvedic, herbal or homeopathic preparation has met the clinical trial standards used by NCCN, ASCO, ESMO or ICMR for cancer treatment. Some carry documented risks, including liver toxicity and interactions with cancer drugs that can reduce their effectiveness.

Not exactly. Your oncologist will plan a number of cycles and will assess your response and tolerance after each one. If the treatment is causing unacceptable harm, if it stops working, or if your situation changes significantly, the plan is reviewed and adjusted. What you should not do is stop chemotherapy on your own without telling your team. Stopping mid-course without clinical review removes the monitoring that allows your team to respond to how you are doing and make those adjustments safely.

There is no established clinical basis for this claim as a general mechanism of how chemotherapy works. This belief may arise because some patients are found to have more widespread disease after starting chemotherapy than was visible at diagnosis. That spread was already occurring — it was not yet detectable on earlier imaging. It is a feature of how cancer behaves, not a consequence of the treatment. NCCN and ASCO guidance does not support chemotherapy causing spread in the way this claim describes.

A cancer returning after chemotherapy does not mean the treatment achieved nothing. Chemotherapy may have controlled the cancer for a sustained period, extended life significantly, or reduced symptoms considerably during treatment. Recurrence is a feature of how many cancers behave over time, not evidence that the original treatment was wrong or unnecessary. When cancer returns, the relevant question is what the next step is — which usually includes further treatment — not whether the first treatment should have been given.